![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Fosamprenavir/Ritonavir (FPV/r) in Hepatically Impaired Subjects: An Observational Multi-Cohort Study
|
|
|
Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
P Nasta,1 D Salmon,2 A D'Arminio Monforte,3 J Pimenta,4 C Cerini,1 E Chiari,1 M Winnock,5 A Cozzi-Lepri6
1Spedali Civili Hospital, Brescia, Italy; 2Universite Paris Descartes, Paris, France; 3San Paolo Hospital, Milan, Italy; 4GlaxoSmithKline, Stockley Park, UK; 5Universite Victor Segalen, Bordeaux, France; 6University College London, London, UK
![ICAAC1.gif](../images/091613/091613-3/ICAAC1.gif)
![ICAAC2.gif](../images/091613/091613-3/ICAAC2.gif)
![ICAAC3.gif](../images/091613/091613-3/ICAAC3.gif)
![ICAAC4.gif](../images/091613/091613-3/ICAAC4.gif)
![ICAAC5.gif](../images/091613/091613-3/ICAAC5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|